查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
家禽疫苗市場-全球市場規模、佔有率、趨勢分析、機遇和預測報告，2019-2029
市場調查報告書
商品編碼
1334463

家禽疫苗市場-全球市場規模、佔有率、趨勢分析、機遇和預測報告，2019-2029

Poultry Vaccines Market - Global Size, Share, Trend Analysis, Opportunity and Forecast Report, 2019-2029, Segmented By Product Type ; By Dosage Form ; By Disease Type ; By Application ; By Region
出版日期: | 出版商: Blueweave Consulting | 英文 400 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

2029年全球家禽疫苗市場規模將達39億美元

由於市場參與者的技術進步以及與家禽疫苗相關的研發活動的增加，全球家禽疫苗市場正在蓬勃發展。

領先的戰略諮詢和市場研究公司 BlueWeave Consulting 最近的一項研究估計，2022 年全球家禽疫苗市場規模為 27.63 億美元。 BlueWeave預測，在2023-2029年預測期內，全球家禽疫苗市場規模將以5.7%的複合年複合成長率顯著成長，到2029年達到38.57億美元。全球家禽疫苗市場的主要成長促進因素包括家禽產量的增加、對家禽產品的需求增加以及人們對疫苗接種在疾病預防中的重要性的認知不斷提高。家禽數量的增加和禽病患病率的增加預計將進一步增加對家禽疫苗的需求。疫苗接種在疾病預防中發揮著重要作用，可以降低與食用受感染肉類相關的風險以及家禽養殖場面臨的挑戰。 2019年，美國雞數量為1972萬隻，巴西雞數量為1460萬隻，這凸顯出大量易感鳥類可以從及時疫苗接種中受益。根據OIE-WAHIS數據庫，特定時期內新發禽類疫情的數量僅為22起，但2020年躍升至836起，估計達到279萬例。該禽類疾病爆發的顯著增加是家禽疫苗市場的主要促進因素。然而，在分析期間，家禽疫苗的副作用、成本高、獲取有限等預計將抑制整體市場的成長。

該報告的詳細分析提供了有關全球家禽疫苗市場的成長潛力、未來趨勢和統計數據的資訊。它還涵蓋了推動市場總規模預測的因素。該報告致力於為決策者提供全球家禽疫苗市場的最新技術趨勢以及行業見解，以做出明智的戰略決策。它還分析了市場的成長促進因素、挑戰和競爭力。

目錄

第1章 研究框架

第2章 執行摘要

第3章 全球家禽疫苗市場洞察

  • 行業價值鏈分析
  • DROC分析
    • 成長促進因素
      • 增加與家禽疫苗相關的研究活動
      • 市場相關人員的重大技術進步
    • 抑制因素
      • 家禽疫苗的副作用
      • 成本高且訪問受限
    • 機會
      • 禽流感疫情
      • 去活化疫苗的使用增加
    • 任務
      • 疾病抗原變異
      • 冷鏈管理
  • 技術進步/最新發展
  • 法律規範
  • 波特五力分析

第4章 全球家禽疫苗市場概況

  • 2019-2029年市場規模及預測
    • 按金額
  • 市場佔有率及預測
    • 按產品類型
      • 減毒活疫苗
      • 去活化疫苗
      • 亞單位疫苗
      • DNA疫苗
      • 重組疫苗
    • 按劑型分
      • 液體疫苗
      • 凍乾疫苗
      • 管
    • 按疾病類型
      • 傳染性支氣管炎
      • 傳染性法氏囊病
      • 傳染性喉氣管炎
      • 丟蛋症候群
      • 腺病毒
      • 鴨病毒性腸炎
      • 包涵體肝炎
      • 球蟲病
      • 禽流感
      • 馬立克氏病
      • 新城疫
      • 沙門氏菌
      • 禽腦脊髓炎
      • 家禽霍亂
    • 按用途
      • 肉雞
      • 層
      • 飼養員
    • 按地區
      • 北美
      • 歐洲
      • 亞太地區 (APAC)
      • 拉丁美洲 (LATAM)
      • 中東和非洲 (MEA)

第5章 北美家禽疫苗市場

  • 2019-2029年市場規模及預測
    • 按金額
  • 市場佔有率及預測
    • 按產品類型
    • 按劑型分
    • 按疾病類型
    • 按用途
    • 按國家/地區
      • 美國
      • 加拿大

第6章 歐洲家禽疫苗市場

  • 2019-2029年市場規模及預測
    • 按金額
  • 市場佔有率及預測
    • 按產品類型
    • 按劑型分
    • 按疾病類型
    • 按用途
    • 按國家/地區
      • 德國
      • 英國
      • 義大利
      • 法國
      • 西班牙
      • 比利時
      • 俄羅斯
      • 荷蘭
      • 其他歐洲國家

第7章 亞太地區家禽疫苗市場

  • 2019-2029年市場規模及預測
    • 按金額
  • 市場佔有率及預測
    • 按產品類型
    • 按劑型分
    • 按疾病類型
    • 按用途
    • 按國家/地區
      • 中國
      • 印度
      • 日本
      • 韓國
      • 澳大利亞和紐西蘭
      • 印度尼西亞
      • 馬來西亞
      • 新加坡
      • 越南
      • 亞太地區其他地區

第8章 拉丁美洲家禽疫苗市場

  • 2019-2029年市場規模及預測
    • 按金額
  • 市場佔有率及預測
    • 按產品類型
    • 按劑型分
    • 按疾病類型
    • 按用途
    • 按國家/地區
      • 巴西
      • 墨西哥
      • 阿根廷
      • 秘魯
      • 拉丁美洲其他地區

第9章 中東及非洲家禽疫苗市場

  • 2019-2029年市場規模及預測
    • 按金額
  • 市場佔有率及預測
    • 按產品類型
    • 按劑型分
    • 按疾病類型
    • 按用途
    • 按國家/地區
      • 沙烏地阿拉伯
      • 阿拉伯聯合大公國
      • 卡達
      • 科威特
      • 南非
      • 奈及利亞
      • 阿爾及利亞
      • MEA 的其餘部分

第10章 競爭格局

  • 主要企業及其產品列表
  • 2022年全球家禽疫苗市場佔有率分析
  • 通過運行參數進行競爭基準測試
  • 主要戰略發展（合併、收購、合作夥伴關係等）

第11章COVID-19對全球家禽疫苗市場的影響

第12章公司簡介（公司簡介、財務矩陣、競爭格局、關鍵人才、主要競爭、聯繫地址、戰略展望、SWOT分析）

  • Boehringer Ingelheim International GmbH
  • Ceva
  • Zoetis
  • Elanco
  • Merck & Co., Inc.
  • Hester Biosciences Limited
  • Vaxxinova International BV
  • Venkys India
  • Calier
  • KM Biologics
  • Phibro Animal Health Corporation
  • Other Prominent Players

第13章關鍵戰略建議

第14章調查方法

  • 定性研究
    • 初級和次級研究
  • 定量研究
  • 市場細分和資料三角測量
    • 二次調查
    • 初步調查
  • 主要調查受訪者的地區分佈
  • 假設和限制
簡介目錄
Product Code: BWC23648

Global Poultry Vaccines Market Size Set to Touch USD 3.9 Billion by 2029.

Global poultry vaccines market is flourishing because of the rising technological advancements by market players and increasing R&D activities associated with poultry vaccines.

BlueWeave Consulting, a leading strategic consulting and market research firm, in its recent study, estimated the global poultry vaccines market size at USD 2.763 billion in 2022. During the forecast period between 2023 and 2029, BlueWeave expects global poultry vaccines market size to grow at a significant CAGR of 5.7% reaching a value of USD 3.857 billion by 2029. Major growth drivers for the global poultry vaccines market include an increasing poultry production, rising demand for poultry products, and growing awareness about the importance of vaccination in disease prevention. The expanding poultry population and the increasing prevalence of avian diseases are expected to further drive the demand for poultry vaccines. To mitigate the risks associated with infected meat consumption and the challenges faced by poultry farms, vaccination plays a crucial role in disease prevention. In 2019, the United States had 19.72 million livestock units of chickens, while Brazil had 14.6 million livestock units, highlighting the considerable number of susceptible birds that could benefit from timely vaccinations. According to the OIE-WAHIS database, there were only 22 new bird outbreaks within a specific period, but this number drastically surged to 836 outbreaks in 2020, with an estimated 2.79 million cases. This significant rise in disease outbreaks among the avian population serves as a key driver for the poultry vaccines market. However, side-effects of poultry vaccines and high costs and limited access are anticipated to restrain the overall market growth during the period in analysis.

Global Poultry Vaccines Market - Overview:

The global poultry vaccines market refers to the worldwide market for vaccines specifically developed for poultry species. Poultry vaccines are used to prevent and control various diseases that affect poultry, including viral, bacterial, and parasitic infections. The market encompasses the research, development, production, and distribution of these vaccines. It plays a crucial role in maintaining the health and productivity of poultry populations, supporting the sustainable growth of the poultry industry. The global poultry vaccines market is driven by increasing poultry production, rising demand for poultry products, and growing awareness of the importance of vaccination in disease prevention.

Impact of COVID-19 on Global Poultry Vaccines Market:

COVID-19 pandemic had a mixed impact on the global poultry vaccines market. On the one hand, there was an increased focus on food safety and biosecurity, which heightened the importance of disease prevention measures, including vaccination, leading to a surge in demand for poultry vaccines. On the other hand, disruptions in the supply chain, restrictions on international trade, and reduced poultry production in some regions posed challenges to the market. Additionally, the diversion of resources toward human health during the pandemic affected R&D activities in the field.

Global Poultry Vaccines Market - By Application:

Based on application, the global poultry vaccines market is divided into Broiler, Layer, and Breeder segments. The breeder segment held the highest market share in 2022 by application due to the increasing number of breeder farms that produce fertile eggs for hatcheries. The enhanced productivity achieved through these breeding farms has greatly contributed to the market's expansion. Government initiatives aimed at vaccinating breeders have played a significant role in driving market growth. Vaccinating breeders not only safeguards the vaccinated birds but also protects the progeny, including broilers. Proactive government policies have resulted in the growth of poultry farmers, breeders, integrators, and feed mills. For example, the Animal Husbandry Department in the state of Andhra Pradesh, India implemented a comprehensive poultry development policy (2016-2020), stimulating production in the poultry sector, promoting egg and chicken processing, and facilitating export activities. Such favorable government initiatives continue to propel the market's growth. Additionally, the market benefits from a favorable regulatory environment and supportive measures that promote sustainable poultry farming practices and ensure food security.

Competitive Landscape:

Major players operating in the global poultry vaccines market include: Boehringer Ingelheim International GmbH, Ceva, Zoetis, Elanco, Merck & Co., Inc., Hester Biosciences Limited, Vaxxinova International BV, Venkys India, Calier, KM Biologics, and Phibro Animal Health Corporation. To further enhance their market share, these companies employ various strategies, including mergers and acquisitions, partnerships, joint ventures, license agreements, and new product launches.

The in-depth analysis of the report provides information about growth potential, upcoming trends, and statistics of Global Poultry Vaccines Market. It also highlights the factors driving forecasts of total market size. The report promises to provide recent technology trends in Global Poultry Vaccines Market and industry insights to help decision-makers make sound strategic decisions. Furthermore, the report also analyzes the growth drivers, challenges, and competitive dynamics of the market.

Table of Contents

1. Research Framework

  • 1.1. Research Objective
  • 1.2. Product Overview
  • 1.3. Market Segmentation

2. Executive Summary

3. Global Poultry Vaccines Market Insights

  • 3.1. Industry Value Chain Analysis
  • 3.2. DROC Analysis
    • 3.2.1. Growth Drivers
      • 3.2.1.1. Increasing Research Activities Associated with Poultry vaccines
      • 3.2.1.2. Huge Technological Advancements by Market Players
    • 3.2.2. Restraints
      • 3.2.2.1. Side-Effects of Poultry Vaccines
      • 3.2.2.2. High Costs and Limited Access
    • 3.2.3. Opportunities
      • 3.2.3.1. Increasing Prevalence of Avian Influenza
      • 3.2.3.2. Increasing Usage of Inactivated Vaccines
    • 3.2.4. Challenges
      • 3.2.4.1. Antigenic Variation of Diseases
      • 3.2.4.2. Cold Chain Management
  • 3.3. Technological Advancements/Recent Developments
  • 3.4. Regulatory Framework
  • 3.5. Porter's Five Forces Analysis
    • 3.5.1. Bargaining Power of Suppliers
    • 3.5.2. Bargaining Power of Buyers
    • 3.5.3. Threat of New Entrants
    • 3.5.4. Threat of Substitutes
    • 3.5.5. Intensity of Rivalry

4. Global Poultry Vaccines Market Overview

  • 4.1. Market Size & Forecast, 2019-2029
    • 4.1.1. By Value (USD Billion)
  • 4.2. Market Share and Forecast
    • 4.2.1. By Product Type
      • 4.2.1.1. Attenuated Live Vaccines
      • 4.2.1.2. Inactivated Vaccines
      • 4.2.1.3. Subunit Vaccines
      • 4.2.1.4. DNA Vaccines
      • 4.2.1.5. Recombinant Vaccines
    • 4.2.2. By Dosage Form
      • 4.2.2.1. Liquid Vaccine
      • 4.2.2.2. Freeze Dried Vaccine
      • 4.2.2.3. Duct
    • 4.2.3. By Disease Type
      • 4.2.3.1. Infectious Bronchitis
      • 4.2.3.2. Infectious Bursal Diseases
      • 4.2.3.3. Infectious Laryngotracheitis
      • 4.2.3.4. Egg Drop Syndrome
      • 4.2.3.5. Adenovirus
      • 4.2.3.6. Duck Viral Enteritis
      • 4.2.3.7. Inclusion Body Hepatitis
      • 4.2.3.8. Coccidiosis
      • 4.2.3.9. Avian Influenza
      • 4.2.3.10. Marek's Disease
      • 4.2.3.11. Newcastle Disease
      • 4.2.3.12. Salmonella
      • 4.2.3.13. Avian Encephalomyelitis
      • 4.2.3.14. Fowl Cholera
    • 4.2.4. By Application
      • 4.2.4.1. Broiler
      • 4.2.4.2. Layer
      • 4.2.4.3. Breeder
    • 4.2.5. By Region
      • 4.2.5.1. North America
      • 4.2.5.2. Europe
      • 4.2.5.3. Asia Pacific (APAC)
      • 4.2.5.4. Latin America (LATAM)
      • 4.2.5.5. Middle East and Africa (MEA)

5. North America Poultry Vaccines Market

  • 5.1. Market Size & Forecast, 2019-2029
    • 5.1.1. By Value (USD Billion)
  • 5.2. Market Share & Forecast
    • 5.2.1. By Product Type
    • 5.2.2. By Dosage Form
    • 5.2.3. By Disease Type
    • 5.2.4. By Application
    • 5.2.5. By Country
      • 5.2.5.1. United States
      • 5.2.5.1.1. By Product Type
      • 5.2.5.1.2. By Dosage Form
      • 5.2.5.1.3. By Disease Type
      • 5.2.5.1.4. By Application
      • 5.2.5.2. Canada
      • 5.2.5.2.1. By Product Type
      • 5.2.5.2.2. By Dosage Form
      • 5.2.5.2.3. By Disease Type
      • 5.2.5.2.4. By Application

6. Europe Poultry Vaccines Market

  • 6.1. Market Size & Forecast, 2019-2029
    • 6.1.1. By Value (USD Billion)
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product Type
    • 6.2.2. By Dosage Form
    • 6.2.3. By Disease Type
    • 6.2.4. By Application
    • 6.2.5. By Country
      • 6.2.5.1. Germany
      • 6.2.5.1.1. By Product Type
      • 6.2.5.1.2. By Dosage Form
      • 6.2.5.1.3. By Disease Type
      • 6.2.5.1.4. By Application
      • 6.2.5.2. United Kingdom
      • 6.2.5.2.1. By Product Type
      • 6.2.5.2.2. By Dosage Form
      • 6.2.5.2.3. By Disease Type
      • 6.2.5.2.4. By Application
      • 6.2.5.3. Italy
      • 6.2.5.3.1. By Product Type
      • 6.2.5.3.2. By Dosage Form
      • 6.2.5.3.3. By Disease Type
      • 6.2.5.3.4. By Application
      • 6.2.5.4. France
      • 6.2.5.4.1. By Product Type
      • 6.2.5.4.2. By Dosage Form
      • 6.2.5.4.3. By Disease Type
      • 6.2.5.4.4. By Application
      • 6.2.5.5. Spain
      • 6.2.5.5.1. By Product Type
      • 6.2.5.5.2. By Dosage Form
      • 6.2.5.5.3. By Disease Type
      • 6.2.5.5.4. By Application
      • 6.2.5.6. Belgium
      • 6.2.5.6.1. By Product Type
      • 6.2.5.6.2. By Dosage Form
      • 6.2.5.6.3. By Disease Type
      • 6.2.5.6.4. By Application
      • 6.2.5.7. Russia
      • 6.2.5.7.1. By Product Type
      • 6.2.5.7.2. By Dosage Form
      • 6.2.5.7.3. By Disease Type
      • 6.2.5.7.4. By Application
      • 6.2.5.8. The Netherlands
      • 6.2.5.8.1. By Product Type
      • 6.2.5.8.2. By Dosage Form
      • 6.2.5.8.3. By Disease Type
      • 6.2.5.8.4. By Application
      • 6.2.5.9. Rest of Europe
      • 6.2.5.9.1. By Product Type
      • 6.2.5.9.2. By Dosage Form
      • 6.2.5.9.3. By Disease Type
      • 6.2.5.9.4. By Application

7. Asia-Pacific Poultry Vaccines Market

  • 7.1. Market Size & Forecast, 2019-2029
    • 7.1.1. By Value (USD Billion)
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product Type
    • 7.2.2. By Dosage Form
    • 7.2.3. By Disease Type
    • 7.2.4. By Application
    • 7.2.5. By Country
      • 7.2.5.1. China
      • 7.2.5.1.1. By Product Type
      • 7.2.5.1.2. By Dosage Form
      • 7.2.5.1.3. By Disease Type
      • 7.2.5.1.4. By Application
      • 7.2.5.2. India
      • 7.2.5.2.1. By Product Type
      • 7.2.5.2.2. By Dosage Form
      • 7.2.5.2.3. By Disease Type
      • 7.2.5.2.4. By Application
      • 7.2.5.3. Japan
      • 7.2.5.3.1. By Product Type
      • 7.2.5.3.2. By Dosage Form
      • 7.2.5.3.3. By Disease Type
      • 7.2.5.3.4. By Application
      • 7.2.5.4. South Korea
      • 7.2.5.4.1. By Product Type
      • 7.2.5.4.2. By Dosage Form
      • 7.2.5.4.3. By Disease Type
      • 7.2.5.4.4. By Application
      • 7.2.5.5. Australia & New Zealand
      • 7.2.5.5.1. By Product Type
      • 7.2.5.5.2. By Dosage Form
      • 7.2.5.5.3. By Disease Type
      • 7.2.5.5.4. By Application
      • 7.2.5.6. Indonesia
      • 7.2.5.6.1. By Product Type
      • 7.2.5.6.2. By Dosage Form
      • 7.2.5.6.3. By Disease Type
      • 7.2.5.6.4. By Application
      • 7.2.5.7. Malaysia
      • 7.2.5.7.1. By Product Type
      • 7.2.5.7.2. By Dosage Form
      • 7.2.5.7.3. By Disease Type
      • 7.2.5.7.4. By Application
      • 7.2.5.8. Singapore
      • 7.2.5.8.1. By Product Type
      • 7.2.5.8.2. By Dosage Form
      • 7.2.5.8.3. By Disease Type
      • 7.2.5.8.4. By Application
      • 7.2.5.9. Vietnam
      • 7.2.5.9.1. By Product Type
      • 7.2.5.9.2. By Dosage Form
      • 7.2.5.9.3. By Disease Type
      • 7.2.5.9.4. By Application
      • 7.2.5.10. Rest of APAC
      • 7.2.5.10.1. By Product Type
      • 7.2.5.10.2. By Dosage Form
      • 7.2.5.10.3. By Disease Type
      • 7.2.5.10.4. By Application

8. Latin America Poultry Vaccines Market

  • 8.1. Market Size & Forecast, 2019-2029
    • 8.1.1. By Value (USD Billion)
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product Type
    • 8.2.2. By Dosage Form
    • 8.2.3. By Disease Type
    • 8.2.4. By Application
    • 8.2.5. By Country
      • 8.2.5.1. Brazil
      • 8.2.5.1.1. By Product Type
      • 8.2.5.1.2. By Dosage Form
      • 8.2.5.1.3. By Disease Type
      • 8.2.5.1.4. By Application
      • 8.2.5.2. Mexico
      • 8.2.5.2.1. By Product Type
      • 8.2.5.2.2. By Dosage Form
      • 8.2.5.2.3. By Disease Type
      • 8.2.5.2.4. By Application
      • 8.2.5.3. Argentina
      • 8.2.5.3.1. By Product Type
      • 8.2.5.3.2. By Dosage Form
      • 8.2.5.3.3. By Disease Type
      • 8.2.5.3.4. By Application
      • 8.2.5.4. Peru
      • 8.2.5.4.1. By Product Type
      • 8.2.5.4.2. By Dosage Form
      • 8.2.5.4.3. By Disease Type
      • 8.2.5.4.4. By Application
      • 8.2.5.5. Rest of LATAM
      • 8.2.5.5.1. By Product Type
      • 8.2.5.5.2. By Dosage Form
      • 8.2.5.5.3. By Disease Type
      • 8.2.5.5.4. By Application

9. Middle East & Africa Poultry Vaccines Market

  • 9.1. Market Size & Forecast, 2019-2029
    • 9.1.1. By Value (USD Billion)
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product Type
    • 9.2.2. By Dosage Form
    • 9.2.3. By Disease Type
    • 9.2.4. By Application
    • 9.2.5. By Country
      • 9.2.5.1. Saudi Arabia
      • 9.2.5.1.1. By Product Type
      • 9.2.5.1.2. By Dosage Form
      • 9.2.5.1.3. By Disease Type
      • 9.2.5.1.4. By Application
      • 9.2.5.2. UAE
      • 9.2.5.2.1. By Product Type
      • 9.2.5.2.2. By Dosage Form
      • 9.2.5.2.3. By Disease Type
      • 9.2.5.2.4. By Application
      • 9.2.5.3. Qatar
      • 9.2.5.3.1. By Product Type
      • 9.2.5.3.2. By Dosage Form
      • 9.2.5.3.3. By Disease Type
      • 9.2.5.3.4. By Application
      • 9.2.5.4. Kuwait
      • 9.2.5.4.1. By Product Type
      • 9.2.5.4.2. By Dosage Form
      • 9.2.5.4.3. By Disease Type
      • 9.2.5.4.4. By Application
      • 9.2.5.5. South Africa
      • 9.2.5.5.1. By Product Type
      • 9.2.5.5.2. By Dosage Form
      • 9.2.5.5.3. By Disease Type
      • 9.2.5.5.4. By Application
      • 9.2.5.6. Nigeria
      • 9.2.5.6.1. By Product Type
      • 9.2.5.6.2. By Dosage Form
      • 9.2.5.6.3. By Disease Type
      • 9.2.5.6.4. By Application
      • 9.2.5.7. Algeria
      • 9.2.5.7.1. By Product Type
      • 9.2.5.7.2. By Dosage Form
      • 9.2.5.7.3. By Disease Type
      • 9.2.5.7.4. By Application
      • 9.2.5.8. Rest of MEA
      • 9.2.5.8.1. By Product Type
      • 9.2.5.8.2. By Dosage Form
      • 9.2.5.8.3. By Disease Type
      • 9.2.5.8.4. By Application

10. Competitive Landscape

  • 10.1. List of Key Players and Their Offerings
  • 10.2. Global Poultry Vaccines Market Share Analysis, 2022
  • 10.3. Competitive Benchmarking, By Operating Parameters
  • 10.4. Key Strategic Developments (Mergers, Acquisitions, Partnerships, etc.)

11. Impact of Covid-19 on Global Poultry Vaccines Market

12. Company Profile (Company Overview, Financial Matrix, Competitive Landscape, Key Personnel, Key Competitors, Contact Address, Strategic Outlook, SWOT Analysis)

  • 12.1. Boehringer Ingelheim International GmbH
  • 12.2. Ceva
  • 12.3. Zoetis
  • 12.4. Elanco
  • 12.5. Merck & Co., Inc.
  • 12.6. Hester Biosciences Limited
  • 12.7. Vaxxinova International BV
  • 12.8. Venkys India
  • 12.9. Calier
  • 12.10. KM Biologics
  • 12.11. Phibro Animal Health Corporation
  • 12.12. Other Prominent Players

13. Key Strategic Recommendations

14. Research Methodology

  • 14.1. Qualitative Research
    • 14.1.1. Primary & Secondary Research
  • 14.2. Quantitative Research
  • 14.3. Market Breakdown & Data Triangulation
    • 14.3.1. Secondary Research
    • 14.3.2. Primary Research
  • 14.4. Breakdown of Primary Research Respondents, By Region
  • 14.5. Assumptions & Limitations